The overall mission of the Biostatistics and Data Management Core (Core G) is to encourage and facilitate high quality innovative, interdisciplinary and translational HIV/AIDS research through effective data management and by supporting the use of rigorous statistical and analytic methodologies;provide educational opportunities for HIV/AIDS researchers on the Penn campus in the use of statistical approaches; assist in building capacity locally and with International partners;and support the overall strategic plan and mission of the Penn CFAR. To achieve these goals, the Specific Aims of the Biostatistics and Data Management Core G are to: A.1. Advise CFAR Investigators on study design and data analysis issues. A.2. Provide statistical collaboration for research funding applications. A.3. Maintain, and facilitate access to, a clinical care database for use in studying the epidemiology of HIV/AIDS, for evaluating feasibility of intervention studies and for facilitating conduct of such studies. A.4. Provide support for design and testing of data collection instruments, data management, and database development. A.5. Provide training in statistical methods to CFAR investigators and our international partners. A.6. Partner with other Cores and specific Programs of the CFAR in interdisciplinary initiatives as well as other CFARs in support of joint goals.

Public Health Relevance

Core G supports CFAR investigators'ability to carry out high quality innovative and translational research by maintaining a clinical database and by providing expertise and education in study design and the use of rigorous statistical and analytical techniques.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI045008-11
Application #
7684975
Study Section
Special Emphasis Panel (ZAI1-SV-A (J3))
Project Start
2009-09-25
Project End
2014-06-30
Budget Start
2009-09-25
Budget End
2010-06-30
Support Year
11
Fiscal Year
2009
Total Cost
$223,489
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Clarke, Erik L; Lauder, Abigail P; Hofstaedter, Casey E et al. (2018) Microbial Lineages in Sarcoidosis. A Metagenomic Analysis Tailored for Low-Microbial Content Samples. Am J Respir Crit Care Med 197:225-234
Venuto, Charles S; Lim, Jihoon; Messing, Susan et al. (2018) Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s. Antivir Ther 23:345-351
Meyers, Kathrine; Rodriguez, Kristina; Brill, Atrina L et al. (2018) Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants. AIDS Behav 22:1209-1216
Barbian, Hannah J; Connell, Andrew Jesse; Avitto, Alexa N et al. (2018) CHIIMP: An automated high-throughput microsatellite genotyping platform reveals greater allelic diversity in wild chimpanzees. Ecol Evol 8:7946-7963
Barbian, Hannah J; Li, Yingying; Ramirez, Miguel et al. (2018) Destabilization of the gut microbiome marks the end-stage of simian immunodeficiency virus infection in wild chimpanzees. Am J Primatol 80:
Abdel-Mohsen, Mohamed; Kuri-Cervantes, Leticia; Grau-Exposito, Judith et al. (2018) CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. Sci Transl Med 10:
Park, Yoon-Dong; Jarvis, Joseph N; Hu, Guowu et al. (2018) Transcriptional Profiling of Patient Isolates Identifies a Novel TOR/Starvation Regulatory Pathway in Cryptococcal Virulence. MBio 9:
Ke, Ruian; Li, Hui; Wang, Shuyi et al. (2018) Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence. Proc Natl Acad Sci U S A 115:E7139-E7148
Veenhuis, Rebecca T; Kwaa, Abena K; Garliss, Caroline C et al. (2018) Long-term remission despite clonal expansion of replication-competent HIV-1 isolates. JCI Insight 3:
MacBrayne, Christine E; Marks, Kristen M; Fierer, Daniel S et al. (2018) Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate. J Antimicrob Chemother 73:2112-2119

Showing the most recent 10 out of 775 publications